New series exploring one asset class each week
'Covid is not going away': Virologist fund manager Dr Ogden on coronavirus, healthcare valuations and biotech opportunities
Single vaccine 'not enough' to treat patients
2019 likely to break the record for IPOs set in 1999
Headlines 'don't reflect the whole story'
David Coombs' Letter from America
Ranking of best developed locations
Key issues for investors
Natalie Kenway reports from San Francisco on the companies that are planning for a future of electric vehicles, anti-ageing technology and 3D printed limbs, with their growth posing a serious threat to older rivals.